Evidence map›Paper›PMID 25370850›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2015

p38 MAPK activation upregulates proinflammatory pathways in skeletal muscle cells from insulin-resistant type 2 diabetic patients.

Audrey E Brown, Jane Palsgaard, Rehannah Borup, Peter Avery, David A Gunn, Pierre De Meyts, Stephen J Yeaman, Mark Walker

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Role of microglia in diabetic neuropathic pain.Frontiers in cell and developmental biology · 2024
    Review
  6. Article
  7. Inflammaging: Implications in Sarcopenia.International journal of molecular sciences · 2022
    Review
  8. Article
  9. Article
  10. Characteristics of the New Insulin-Resistant Zebrafish Model.Pharmaceuticals (Basel, Switzerland) · 2021
    Article
  11. Review
  12. p38 MAPK in Glucose Metabolism of Skeletal Muscle: Beneficial or Harmful?International journal of molecular sciences · 2020
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Differential expression of genes and differentially perturbed pathways associated with very high evening fatigue in oncology patients receiving chemotherapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2018
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Audrey E BrownInstitute of Cellular Medicine, Newcastle University, Newcastle, United Kingdom;
Jane PalsgaardReceptor Systems Biology Laboratory, Hagedorn Research Institute, Novo Nordisk, Gentofte, Denmark;
Rehannah BorupDepartment of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark;
Peter AverySchool of Mathematics and Statistics, Newcastle University, Newcastle, United Kingdom; and.
David A GunnUnilever Discover, Colworth Science Park, Sharnbrook, Bedford, United Kingdom.
Pierre De MeytsReceptor Systems Biology Laboratory, Hagedorn Research Institute, Novo Nordisk, Gentofte, Denmark;
Stephen J YeamanInstitute of Cellular Medicine, Newcastle University, Newcastle, United Kingdom;
Mark WalkerInstitute of Cellular Medicine, Newcastle University, Newcastle, United Kingdom; mark.walker@ncl.ac.uk.
Newcastle University · GBNovo Nordisk (Denmark) · DKUnilever (United Kingdom) · GBUniversity of Copenhagen · DK

Funding

Department of Health
6 · The paper itself

Abstract

Skeletal muscle is the key site of peripheral insulin resistance in type 2 diabetes. Insulin-stimulated glucose uptake is decreased in differentiated diabetic cultured myotubes, which is in keeping with a retained genetic/epigenetic defect of insulin action. We investigated differences in gene expression during differentiation between diabetic and control muscle cell cultures. Microarray analysis was performed using skeletal muscle cell cultures established from type 2 diabetic patients with a family history of type 2 diabetes and clinical evidence of marked insulin resistance and nondiabetic control subjects with no family history of diabetes. Genes and pathways upregulated with differentiation in the diabetic cultures, compared with controls, were identified using Gene Spring and Gene Set Enrichment Analysis. Gene sets upregulated in diabetic myotubes were associated predominantly with inflammation. p38 MAPK was identified as a key regulator of the expression of these proinflammatory gene sets, and p38 MAPK activation was found to be increased in the diabetic vs. control myotubes. Although inhibition of p38 MAPK activity decreased cytokine gene expression from the cultured diabetic myotubes significantly, it did not improve insulin-stimulated glucose uptake. Increased cytokine expression driven by increased p38 MAPK activation is a key feature of cultured myotubes derived from insulin-resistant type 2 diabetic patients. p38 MAPK inhibition decreased cytokine expression but did not affect the retained defect of impaired insulin action in the diabetic muscle cells.

Indexed as

Insulin ResistanceAgedCase-Control StudiesCells, CulturedDiabetes Mellitus, Type 2Enzyme ActivationFemaleHumansInflammationInflammation MediatorsMaleMiddle AgedMuscle, Skeletalp38 Mitogen-Activated Protein KinasesSignal TransductionUp-RegulationInflammation Mediatorsp38 Mitogen-Activated Protein Kinasescytokineshuman skeletal muscle cellsinflammationinsulin resistancep38 mitogen-activated protein kinase

Identifiers

PMID25370850
PMCPMC4281683
OpenAlexW2159406227

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.